Global Nuclear Medicine Radioisotopes Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Market Overview

• 1.1 Nuclear Medicine Radioisotopes Introduction
• 1.2 Market Analysis by Type
  • 1.2.1 Thallium-201 (Tl-201)
  • 1.2.2 Iodine (I-123)
  • 1.2.3 Fluorine-18
  • 1.2.4 Rubidium-82 (Rb-82)
  • 1.2.5 Other
• 1.3 Market Analysis by Applications
  • 1.3.1 Tumor
  • 1.3.2 Heart Disease
  • 1.3.3 Lymphoma
  • 1.3.4 Thyroid Gland
  • 1.3.5 Other
• 1.4 Market Analysis by Regions
  • 1.4.1 North America (United States, Canada and Mexico)
    • 1.4.1.1 United States Market States and Outlook (2014-2024)
    • 1.4.1.2 Canada Market States and Outlook (2014-2024)
    • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
    • 1.4.2.1 Germany Market States and Outlook (2014-2024)
    • 1.4.2.2 France Market States and Outlook (2014-2024)
    • 1.4.2.3 UK Market States and Outlook (2014-2024)
    • 1.4.2.4 Russia Market States and Outlook (2014-2024)
    • 1.4.2.5 Italy Market States and Outlook (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    • 1.4.3.1 China Market States and Outlook (2014-2024)
    • 1.4.3.2 Japan Market States and Outlook (2014-2024)
    • 1.4.3.3 Korea Market States and Outlook (2014-2024)
    • 1.4.3.4 India Market States and Outlook (2014-2024)
    • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
  • 1.4.4 South America, Middle East and Africa
    • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
    • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
    • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
    • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
    • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
• 1.5 Market Dynamics
  • 1.5.1 Market Opportunities
  • 1.5.2 Market Risk
  • 1.5.3 Market Driving Force

2 Manufacturers Profiles

• 2.1 Agfa-Gevaert Group
  • 2.1.1 Business Overview
  • 2.1.2 Nuclear Medicine Radioisotopes Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Agfa-Gevaert Group Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 Braco
  • 2.2.1 Business Overview
  • 2.2.2 Nuclear Medicine Radioisotopes Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Braco Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 Cardiarc
  • 2.3.1 Business Overview
  • 2.3.2 Nuclear Medicine Radioisotopes Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Cardiarc Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Cardinal Health
  • 2.4.1 Business Overview
  • 2.4.2 Nuclear Medicine Radioisotopes Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Cardinal Health Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 CMR Naviscan (Gamma Medica Inc.)
  • 2.5.1 Business Overview
  • 2.5.2 Nuclear Medicine Radioisotopes Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Curium
  • 2.6.1 Business Overview
  • 2.6.2 Nuclear Medicine Radioisotopes Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Curium Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Digirad
  • 2.7.1 Business Overview
  • 2.7.2 Nuclear Medicine Radioisotopes Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Digirad Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 GE Healthcare
  • 2.8.1 Business Overview
  • 2.8.2 Nuclear Medicine Radioisotopes Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 GE Healthcare Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 Nordion (Canada)
  • 2.9.1 Business Overview
  • 2.9.2 Nuclear Medicine Radioisotopes Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 Nordion (Canada) Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 NTP Radioisotopes SOC
  • 2.10.1 Business Overview
  • 2.10.2 Nuclear Medicine Radioisotopes Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.11 Positron
  • 2.11.1 Business Overview
  • 2.11.2 Nuclear Medicine Radioisotopes Type and Applications
    • 2.11.2.1 Product A
    • 2.11.2.2 Product B
  • 2.11.3 Positron Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.12 Segami
  • 2.12.1 Business Overview
  • 2.12.2 Nuclear Medicine Radioisotopes Type and Applications
    • 2.12.2.1 Product A
    • 2.12.2.2 Product B
  • 2.12.3 Segami Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
• 2.13 Siemens Healthcare
  • 2.13.1 Business Overview
  • 2.13.2 Nuclear Medicine Radioisotopes Type and Applications
    • 2.13.2.1 Product A
    • 2.13.2.2 Product B
  • 2.13.3 Siemens Healthcare Nuclear Medicine Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

3 Global Nuclear Medicine Radioisotopes Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

• 3.1 Global Nuclear Medicine Radioisotopes Sales and Market Share by Manufacturer (2017-2018)
• 3.2 Global Nuclear Medicine Radioisotopes Revenue and Market Share by Manufacturer (2017-2018)
• 3.3 Market Concentration Rate
  • 3.3.1 Top 3 Nuclear Medicine Radioisotopes Manufacturer Market Share in 2018
  • 3.3.2 Top 6 Nuclear Medicine Radioisotopes Manufacturer Market Share in 2018
• 3.4 Market Competition Trend

4 Global Nuclear Medicine Radioisotopes Market Analysis by Regions

• 4.1 Global Nuclear Medicine Radioisotopes Sales, Revenue and Market Share by Regions
  • 4.1.1 Global Nuclear Medicine Radioisotopes Sales and Market Share by Regions (2014-2019)
  • 4.1.2 Global Nuclear Medicine Radioisotopes Revenue and Market Share by Regions (2014-2019)
• 4.2 North America Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
• 4.3 Europe Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
• 4.5 South America Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)

5 North America Nuclear Medicine Radioisotopes by Country

• 5.1 North America Nuclear Medicine Radioisotopes Sales, Revenue and Market Share by Country
  • 5.1.1 North America Nuclear Medicine Radioisotopes Sales and Market Share by Country (2014-2019)
  • 5.1.2 North America Nuclear Medicine Radioisotopes Revenue and Market Share by Country (2014-2019)
• 5.2 United States Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
• 5.3 Canada Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
• 5.4 Mexico Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)

6 Europe Nuclear Medicine Radioisotopes by Country

• 6.1 Europe Nuclear Medicine Radioisotopes Sales, Revenue and Market Share by Country
  • 6.1.1 Europe Nuclear Medicine Radioisotopes Sales and Market Share by Country (2014-2019)
  • 6.1.2 Europe Nuclear Medicine Radioisotopes Revenue and Market Share by Country (2014-2019)
• 6.2 Germany Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
• 6.3 UK Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
• 6.4 France Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
• 6.5 Russia Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
• 6.6 Italy Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)

7 Asia-Pacific Nuclear Medicine Radioisotopes by Country

• 7.1 Asia-Pacific Nuclear Medicine Radioisotopes Sales, Revenue and Market Share by Country
  • 7.1.1 Asia-Pacific Nuclear Medicine Radioisotopes Sales and Market Share by Country (2014-2019)
  • 7.1.2 Asia-Pacific Nuclear Medicine Radioisotopes Revenue and Market Share by Country (2014-2019)
• 7.2 China Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
• 7.3 Japan Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
• 7.4 Korea Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
• 7.5 India Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
• 7.6 Southeast Asia Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)

8 South America Nuclear Medicine Radioisotopes by Country

• 8.1 South America Nuclear Medicine Radioisotopes Sales, Revenue and Market Share by Country
  • 8.1.1 South America Nuclear Medicine Radioisotopes Sales and Market Share by Country (2014-2019)
  • 8.1.2 South America Nuclear Medicine Radioisotopes Revenue and Market Share by Country (2014-2019)
• 8.2 Brazil Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
• 8.3 Argentina Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
• 8.4 Colombia Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)

9 Middle East and Africa Nuclear Medicine Radioisotopes by Countries

• 9.1 Middle East and Africa Nuclear Medicine Radioisotopes Sales, Revenue and Market Share by Country
  • 9.1.1 Middle East and Africa Nuclear Medicine Radioisotopes Sales and Market Share by Country (2014-2019)
  • 9.1.2 Middle East and Africa Nuclear Medicine Radioisotopes Revenue and Market Share by Country (2014-2019)
• 9.2 Saudi Arabia Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
• 9.3 Turkey Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
• 9.4 Egypt Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
• 9.5 Nigeria Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)
• 9.6 South Africa Nuclear Medicine Radioisotopes Sales and Growth Rate (2014-2019)

10 Global Nuclear Medicine Radioisotopes Market Segment by Type

• 10.1 Global Nuclear Medicine Radioisotopes Sales, Revenue and Market Share by Type (2014-2019)
  • 10.1.1 Global Nuclear Medicine Radioisotopes Sales and Market Share by Type (2014-2019)
  • 10.1.2 Global Nuclear Medicine Radioisotopes Revenue and Market Share by Type (2014-2019)
• 10.2 Thallium-201 (Tl-201) Sales Growth and Price
  • 10.2.1 Global Thallium-201 (Tl-201) Sales Growth (2014-2019)
  • 10.2.2 Global Thallium-201 (Tl-201) Price (2014-2019)
• 10.3 Iodine (I-123) Sales Growth and Price
  • 10.3.1 Global Iodine (I-123) Sales Growth (2014-2019)
  • 10.3.2 Global Iodine (I-123) Price (2014-2019)
• 10.4 Fluorine-18 Sales Growth and Price
  • 10.4.1 Global Fluorine-18 Sales Growth (2014-2019)
  • 10.4.2 Global Fluorine-18 Price (2014-2019)
• 10.5 Rubidium-82 (Rb-82) Sales Growth and Price
  • 10.5.1 Global Rubidium-82 (Rb-82) Sales Growth (2014-2019)
  • 10.5.2 Global Rubidium-82 (Rb-82) Price (2014-2019)
• 10.6 Other Sales Growth and Price
  • 10.6.1 Global Other Sales Growth (2014-2019)
  • 10.6.2 Global Other Price (2014-2019)

11 Global Nuclear Medicine Radioisotopes Market Segment by Application

• 11.1 Global Nuclear Medicine Radioisotopes Sales Market Share by Application (2014-2019)
• 11.2 Tumor Sales Growth (2014-2019)
• 11.3 Heart Disease Sales Growth (2014-2019)
• 11.4 Lymphoma Sales Growth (2014-2019)
• 11.5 Thyroid Gland Sales Growth (2014-2019)
• 11.6 Other Sales Growth (2014-2019)

12 Nuclear Medicine Radioisotopes Market Forecast (2019-2024)

• 12.1 Global Nuclear Medicine Radioisotopes Sales, Revenue and Growth Rate (2019-2024)
• 12.2 Nuclear Medicine Radioisotopes Market Forecast by Regions (2019-2024)
  • 12.2.1 North America Nuclear Medicine Radioisotopes Market Forecast (2019-2024)
  • 12.2.2 Europe Nuclear Medicine Radioisotopes Market Forecast (2019-2024)
  • 12.2.3 Asia-Pacific Nuclear Medicine Radioisotopes Market Forecast (2019-2024)
  • 12.2.4 South America Nuclear Medicine Radioisotopes Market Forecast (2019-2024)
  • 12.2.5 Middle East and Africa Nuclear Medicine Radioisotopes Market Forecast (2019-2024)
• 12.3 Nuclear Medicine Radioisotopes Market Forecast by Type (2019-2024)
  • 12.3.1 Global Nuclear Medicine Radioisotopes Sales Forecast by Type (2019-2024)
  • 12.3.2 Global Nuclear Medicine Radioisotopes Market Share Forecast by Type (2019-2024)
• 12.4 Nuclear Medicine Radioisotopes Market Forecast by Application (2019-2024)
  • 12.4.1 Global Nuclear Medicine Radioisotopes Sales Forecast by Application (2019-2024)
  • 12.4.2 Global Nuclear Medicine Radioisotopes Market Share Forecast by Application (2019-2024)

13 Sales Channel, Distributors, Traders and Dealers

• 13.1 Sales Channel
  • 13.1.1 Direct Marketing
  • 13.1.2 Indirect Marketing
  • 13.1.3 Marketing Channel Future Trend
• 13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

• 15.1 Methodology